New medicine insert rules effective Friday

June 29, 2006

U.S. pharmaceutical companies this Friday will begin using clearer, more understandable package inserts for some of their newer prescription drugs.

While that might be a positive step in improving medication use, some experts worry the change will make it more difficult to sue drug manufacturers for product liability.

The U.S. Food and Drug Administration requirement calls for more concise and better organized patient information package insert sheets. The inserts will include a table of contents, a toll-free number for reporting of adverse drug events, the initial date of FDA product approval and a section that will summarize some of the most important drug information, including benefits, risks and usage.

Assistant Professor of Pharmacy Practice at Wilkes University in Wilkes-Barre, Pa., Dominick Trombetta, says the new rules will help minimize adverse drug reactions and medication errors.

But Trombetta says he is concerned the label changes will make it more difficult to sue drug manufacturers over product liability.

"FDA's response to drug manufacturer's concerns over increased liability was to include wording that would exempt them from state product liability," a decision he says is "extremely disturbing" and which is likely to be challenged in court.

Copyright 2006 by United Press International

Explore further: Stanford patient is first infant to receive lifesaving drug for neurodegenerative disease

Related Stories

Senate votes to move bill speeding federal drug OKs

December 5, 2016

The Senate moved Monday toward removing the last hurdles to legislation bolstering disease research and simplifying the government's pathway for pharmaceutical and medical device approvals as a Congress marked by frequent ...

Antidepressant effects of ketamine

December 8, 2016

New preclinical evidence was put forward by investigators in a series of presentations at the recent meeting of the American College of Neuropsychopharmacology suggest that the a metabolite of ketamine can produce antidepressant-like ...

Linking Gaucher and Parkinson's Diseases

December 9, 2016

Gaucher (pronounced "go-shay") disease affects one in 450 Jewish people of Ashkenazi (eastern European) descent (one in 10 is a carrier), yet only 1 in 40,000 people in the general population. Of course mutations can happen ...

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.